Back to Stock Dashboard
Sector:
General
Add to portfolio
LABD
Direxion Daily S&P Biotech Bear 3X Shares
CAPPED RATING
Direxion Daily S&P Biotech Bear 3X Shares (LABD) is rated C+ (2.8/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Risk (A+); its weakest is Momentum (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.8
/ 5.0
C+
Expenses
B-
Factor Score
3.0
/ 5.0
Liquidity
B
Factor Score
3.5
/ 5.0
Risk
A+
Factor Score
4.9
/ 5.0
Momentum
D
Factor Score
1.4
/ 5.0
Yield
C+
Factor Score
2.5
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Avg Volume
9.2M
Beta
-3.2
Max Drawdown
N/A
Price Return 3M
-39.5%
Price Return 12M
-86.9%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-08-05 | B- (3.0) | B (3.5) | A+ (4.9) | D (1.4) | C+ (2.5) | C+ (2.8) |
| 2026-08-04 | B- (3.0) | B (3.5) | A+ (5.0) | D (1.5) | C+ (2.5) | B- (2.9) |
| 2026-08-03 | B- (2.9) | B- (3.1) | B (3.3) | D (1.5) | C+ (2.5) | C+ (2.5) |
| 2026-08-02 | B- (2.9) | B (3.2) | B (3.3) | D (1.5) | C+ (2.5) | C+ (2.5) |